The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-p-tolyl-4-(trifluoromethyl)-[1,2,4]triazolo[4,3-a]quinoxaline ID: ALA1275633
Cas Number: 343372-45-2
PubChem CID: 3310540
Max Phase: Preclinical
Molecular Formula: C17H11F3N4
Molecular Weight: 328.30
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cc1ccc(-c2nnc3c(C(F)(F)F)nc4ccccc4n23)cc1
Standard InChI: InChI=1S/C17H11F3N4/c1-10-6-8-11(9-7-10)15-22-23-16-14(17(18,19)20)21-12-4-2-3-5-13(12)24(15)16/h2-9H,1H3
Standard InChI Key: PDEQZKMFUXKNAX-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 27 0 0 0 0 0 0 0 0999 V2000
-5.1056 -3.9541 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.1068 -4.7815 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.3919 -5.1944 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.3937 -3.5414 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.6784 -3.9505 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.6776 -4.7773 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.2520 -3.9436 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.9679 -3.5363 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.2473 -4.7735 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.9639 -5.1849 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.7942 -5.9936 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.9725 -6.0821 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.6346 -5.3281 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.3478 -6.6053 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.1532 -6.4268 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.7066 -7.0377 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.4538 -7.8240 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.6426 -7.9959 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.0927 -7.3836 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.5401 -3.5267 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.8231 -3.9349 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
-1.5451 -2.7017 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
-0.9603 -2.9398 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
-5.0066 -8.4364 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5 6 1 0
10 11 1 0
11 12 2 0
12 13 1 0
13 9 2 0
6 10 1 0
11 14 1 0
3 6 2 0
14 15 2 0
9 7 1 0
15 16 1 0
1 2 2 0
16 17 2 0
7 8 2 0
17 18 1 0
8 5 1 0
18 19 2 0
19 14 1 0
9 10 1 0
7 20 1 0
5 4 2 0
20 21 1 0
4 1 1 0
20 22 1 0
20 23 1 0
2 3 1 0
17 24 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 328.30Molecular Weight (Monoisotopic): 328.0936AlogP: 4.27#Rotatable Bonds: 1Polar Surface Area: 43.08Molecular Species: NEUTRALHBA: 4HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 0.94CX LogP: 3.79CX LogD: 3.79Aromatic Rings: 4Heavy Atoms: 24QED Weighted: 0.52Np Likeness Score: -1.64
References 1. Carosati E, Sforna G, Pippi M, Marverti G, Ligabue A, Guerrieri D, Piras S, Guaitoli G, Luciani R, Costi MP, Cruciani G.. (2010) Ligand-based virtual screening and ADME-tox guided approach to identify triazolo-quinoxalines as folate cycle inhibitors., 18 (22): [PMID:20951595 ] [10.1016/j.bmc.2010.09.065 ] 2. PubChem BioAssay data set, 3. Antonova-Koch Y, Meister S, Abraham M, Luth MR, Ottilie S, Lukens AK, Sakata-Kato T, Vanaerschot M, Owen E, Jado JC, Maher SP, Calla J, Plouffe D, Zhong Y, Chen K, Chaumeau V, Conway AJ, McNamara CW, Ibanez M, Gagaring K, Serrano FN, Eribez K, Taggard CM, Cheung AL, Lincoln C, Ambachew B, Rouillier M, Siegel D, Nosten F, Kyle DE, Gamo FJ, Zhou Y, Llinás M, Fidock DA, Wirth DF, Burrows J, Campo B, Winzeler EA.. (2018) Open-source discovery of chemical leads for next-generation chemoprotective antimalarials., 362 (6419): [PMID:30523084 ] [10.1126/science.aat9446 ]